Dyslipidemia Completed Phase 4 Trials for Pyridoxine (DB00165)

Also known as: Dyslipaemia / Dyslipidaemia / Dyslipidemias / Dyslipidaemias

IndicationStatusPhase
DBCOND0020718 (Dyslipidemia)Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03221816Effect of Polyvitaminics (Pyridoxine Hydrochloride, Folic Acid and Cyanocobalamin) in the Concentration of Homocysteine and Lipid Profile in Postmenopausal Women: a Randomized Controlled, Double-blind Clinical TrialPrevention